1Key Laboratory of Mariculture, Ministry of Education, Ocean University of China, 266003 Qingdao, China.
2Laboratory for Marine Fisheries Science and Food Production Processes, Qingdao National Laboratory for Marine Science and Technology, 266003 Qingdao, China.
Commun Biol. 2019 Jun 21;2:231. doi: 10.1038/s42003-019-0484-5. eCollection 2019.
Receptor tyrosine kinases (RTK) have been the most prevalent therapeutic targets in anti-cancer drug development. However, the emergence of drug resistance toward single target RTK inhibitors remains a major challenge to achieve long-term remissions. Development of alternative RTK inhibitory strategies that bypass drug resistance is much wanted. In the present study, we found that selected cell surface RTKs were inhibited and crosslinked into detergent resistant complexes by oligomeric but not monomeric concanavalin A (ConA). The inhibition of RTKs by ConA led to suppression of pro-survival pathways and induction of apoptosis in multiple cancer cell lines, while overexpression of constitutively activated protein kinase B (AKT) reversed the apoptotic effect. However, major cell stress sensing checkpoints were not influenced by ConA. To our knowledge, selective crosslinking and inhibition of cell surface receptors by ConA-like molecules might represent a previously unidentified mechanism that could be potentially exploited for therapeutic development.
受体酪氨酸激酶 (RTK) 一直是抗癌药物开发中最常见的治疗靶点。然而,针对单一靶点 RTK 抑制剂的耐药性的出现仍然是实现长期缓解的主要挑战。开发绕过耐药性的替代 RTK 抑制策略是非常需要的。在本研究中,我们发现,寡聚但不是单体的伴刀豆球蛋白 A (ConA) 可抑制选定的细胞表面 RTK 并将其交联成去污剂抗性复合物。ConA 对 RTKs 的抑制导致抗生存途径的抑制和多种癌细胞系的凋亡诱导,而组成型激活蛋白激酶 B (AKT) 的过表达逆转了凋亡作用。然而,ConA 并不影响主要的细胞应激感应检查点。据我们所知,ConA 样分子对细胞表面受体的选择性交联和抑制可能代表一种以前未被识别的机制,可潜在地用于治疗开发。